retatrutide kit bundle Repair & Metabolic Bundle: BPC-157, TB-500, Retatrutide Pen 10mg | High-Purity

A landmark study published in Diabetes (Tolhurst et al., 2012) demonstrated that SCFAs stimulate GLP-1 secretion via the FFAR2 receptor, and that mice lacking this receptor showed significantly reduced SCFA-triggered GLP-1 release

GLP-1 receptor agonists are no longer niche therapies

The compound is frequently referred to as a triple-hormone-receptor agonist retatrutide because it simultaneously targets: GLP-1 receptor pathways Glucagon receptor pathways Glucose-dependent insulinotropic polypeptide receptor pathways This triple agonist mechanism differentiates retatrutide from earlier GLP-1 receptor agonist compounds and other research peptides currently studied for obesity and metabolic dysfunction

June 2025: A petition has been filed to group together Ozempic vision loss lawsuits in New Jersey state court